{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0069-0231",
      "generic_name": "lorlatinib",
      "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
      "brand_name": "Lorbrena",
      "active_ingredients": [
        {
          "name": "LORLATINIB",
          "strength": "100 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0069-0231-01",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (0069-0231-01)",
          "marketing_start_date": "20181119",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Pfizer Laboratories Div Pfizer Inc"
        ],
        "rxcui": [
          "2103169",
          "2103175",
          "2103177",
          "2103179"
        ],
        "spl_set_id": [
          "2b34d62d-e02a-4af3-bc0d-1571dd4ee76d"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0300690231013",
          "0300690227016"
        ],
        "nui": [
          "N0000175605",
          "N0000175082",
          "N0000190118",
          "N0000191264",
          "N0000187064",
          "N0000191265",
          "N0000190111",
          "N0000191423",
          "N0000190113"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Kinase Inhibitors [MoA]",
          "Cytochrome P450 3A Inducers [MoA]",
          "P-Glycoprotein Inducers [MoA]",
          "Cytochrome P450 2B6 Inducers [MoA]",
          "Organic Cation Transporter 1 Inhibitors [MoA]",
          "Organic Anion Transporter 3 Inhibitors [MoA]",
          "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]"
        ],
        "unii": [
          "OSP71S83EU"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "46cb56ce-da15-49af-b72b-f9e377cae4a6",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20181119",
      "product_id": "0069-0231_46cb56ce-da15-49af-b72b-f9e377cae4a6",
      "application_number": "NDA210868",
      "brand_name_base": "Lorbrena",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 2B6 Inducers [MoA]",
        "Cytochrome P450 3A Inducers [MoA]",
        "Kinase Inhibitor [EPC]",
        "Kinase Inhibitors [MoA]",
        "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]",
        "Organic Anion Transporter 3 Inhibitors [MoA]",
        "Organic Cation Transporter 1 Inhibitors [MoA]",
        "P-Glycoprotein Inducers [MoA]"
      ]
    }
  ]
}